These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 17114186)
1. ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers. Handattu SP; Garber DW; Horn DC; Hughes DW; Berno B; Bain AD; Mishra VK; Palgunachari MN; Datta G; Anantharamaiah GM; Epand RM J Biol Chem; 2007 Jan; 282(3):1980-8. PubMed ID: 17114186 [TBL] [Abstract][Full Text] [Related]
2. Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity. Datta G; Epand RF; Epand RM; Chaddha M; Kirksey MA; Garber DW; Lund-Katz S; Phillips MC; Hama S; Navab M; Fogelman AM; Palgunachari MN; Segrest JP; Anantharamaiah GM J Biol Chem; 2004 Jun; 279(25):26509-17. PubMed ID: 15075321 [TBL] [Abstract][Full Text] [Related]
3. Two homologous apolipoprotein AI mimetic peptides. Relationship between membrane interactions and biological activity. Epand RM; Epand RF; Sayer BG; Datta G; Chaddha M; Anantharamaiah GM J Biol Chem; 2004 Dec; 279(49):51404-14. PubMed ID: 15358763 [TBL] [Abstract][Full Text] [Related]
4. Effect of leucine to phenylalanine substitution on the nonpolar face of a class A amphipathic helical peptide on its interaction with lipid: high resolution solution NMR studies of 4F-dimyristoylphosphatidylcholine discoidal complex. Mishra VK; Palgunachari MN; Krishna R; Glushka J; Segrest JP; Anantharamaiah GM J Biol Chem; 2008 Dec; 283(49):34393-402. PubMed ID: 18845546 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function. Anantharamaiah GM; Garber DW; White CR Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181 [TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. Van Lenten BJ; Wagner AC; Jung CL; Ruchala P; Waring AJ; Lehrer RI; Watson AD; Hama S; Navab M; Anantharamaiah GM; Fogelman AM J Lipid Res; 2008 Nov; 49(11):2302-11. PubMed ID: 18621920 [TBL] [Abstract][Full Text] [Related]
7. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. Datta G; Chaddha M; Hama S; Navab M; Fogelman AM; Garber DW; Mishra VK; Epand RM; Epand RF; Lund-Katz S; Phillips MC; Segrest JP; Anantharamaiah GM J Lipid Res; 2001 Jul; 42(7):1096-104. PubMed ID: 11441137 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein A-I adopts a belt-like orientation in reconstituted high density lipoproteins. Panagotopulos SE; Horace EM; Maiorano JN; Davidson WS J Biol Chem; 2001 Nov; 276(46):42965-70. PubMed ID: 11557764 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-I Mimetic Peptides: Discordance Between In Vitro and In Vivo Properties-Brief Report. Ditiatkovski M; Palsson J; Chin-Dusting J; Remaley AT; Sviridov D Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1301-1306. PubMed ID: 28522696 [TBL] [Abstract][Full Text] [Related]
11. Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides. Anantharamaiah GM; Mishra VK; Garber DW; Datta G; Handattu SP; Palgunachari MN; Chaddha M; Navab M; Reddy ST; Segrest JP; Fogelman AM J Lipid Res; 2007 Sep; 48(9):1915-23. PubMed ID: 17570869 [TBL] [Abstract][Full Text] [Related]
12. CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice. Tardy C; Goffinet M; Boubekeur N; Ackermann R; Sy G; Bluteau A; Cholez G; Keyserling C; Lalwani N; Paolini JF; Dasseux JL; Barbaras R; Baron R Atherosclerosis; 2014 Jan; 232(1):110-8. PubMed ID: 24401224 [TBL] [Abstract][Full Text] [Related]
13. Evidence for a central apolipoprotein A-I domain loosely bound to lipids in discoidal lipoproteins that is capable of penetrating the bilayer of phospholipid vesicles. Córsico B; Toledo JD; Garda HA J Biol Chem; 2001 May; 276(20):16978-85. PubMed ID: 11278925 [TBL] [Abstract][Full Text] [Related]
15. Association of a model class A (apolipoprotein) amphipathic alpha helical peptide with lipid: high resolution NMR studies of peptide.lipid discoidal complexes. Mishra VK; Anantharamaiah GM; Segrest JP; Palgunachari MN; Chaddha M; Sham SW; Krishna NR J Biol Chem; 2006 Mar; 281(10):6511-9. PubMed ID: 16407255 [TBL] [Abstract][Full Text] [Related]
16. Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice. Qin S; Kamanna VS; Lai JH; Liu T; Ganji SH; Zhang L; Bachovchin WW; Kashyap ML J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):334-43. PubMed ID: 22308547 [TBL] [Abstract][Full Text] [Related]
18. The effect of HDL mimetic peptide 4F on PON1. Vakili L; Hama S; Kim JB; Tien D; Safarpoor S; Ly N; Vakili G; Hough G; Navab M Adv Exp Med Biol; 2010; 660():167-72. PubMed ID: 20221879 [TBL] [Abstract][Full Text] [Related]
19. Peptides as Therapeutic Agents for Atherosclerosis. White CR; Palgunachari M; Wolkowicz P; Anantharamaiah GM Methods Mol Biol; 2022; 2419():89-110. PubMed ID: 35237960 [TBL] [Abstract][Full Text] [Related]
20. Intracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytes. Maric J; Kiss RS; Franklin V; Marcel YL J Biol Chem; 2005 Dec; 280(48):39942-9. PubMed ID: 16204232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]